Alexandre Loupy
Alexandre Loupy, MD PhD, is the director of PITOR (Paris Institut of Transplantation and Organ Regeneration). He is also a professor of Nephrology working in the kidney transplant department of Necker Hospital.
Pr. Loupy defended two PhDs, in cell biology (2011) and in biostatistics (2014).
His research focuses on artificial intelligence and multi-organ transplantation analytics. It covers allograft transplantation, rejection, antibodies and populational sciences.
Since 2015, Pr. Loupy is the head of the Paris Transplant Group (PTG) in PARCC U970.
Then, he founded PITOR (Paris Institut of Transplantation and Organ Regeneration) in 2023.
PITOR is recognised in the transplant research field for high impact factor quality epidemiologic research and has changed clinical practice with wide implementation of discoveries into clinical practice.
Pr. Loupy has also been appointed Professor of Nephrology and Epidemiology Kidney Transplant department at the Necker Hospital in Paris, France in 2017 and adjunct Professor at Cedars Sinaï, UCLA, California, USA, in 2020. Since 2025, he is also Adjunct Professor in the Department of Surgery at NYU Grossman School of Medicine.
Pr. Loupy has been appointed as Director of the Banff Scientific Committee for allograft classification in 2014 and contributes to the working groups (22 transplant centres represented worldwide), and Banff recommendations delivered to the international transplant community.
Pr. Loupy is also an expert for the FDA and a member of the American Society of Transplantation. He got the Clinical science investigator award from the AST in 2017 and was awarded the National Academy of Medicine Award for his work on « Renal transplantation, anti-HLA graft rejection, and biomarker identification ». Dr Loupy is also involved in the French Society of Transplantation and in the European Society of Transplantation. In 2025, he was elected Councilor at the international xenotransplantation association.
Pr. Loupy was Associate Editor for the Transplantation Journal from 2014 to 2018, and still is at the American Journal of Transplantation. He is also referee for the New England Journal of Medicine, Nature Medicine, The Lancet, JAMA, the American Journal of Transplantation, Kidney International, Plos Medicine and the Journal of the American Society of Nephrology.
In the past years, Pr. Loupy has obtained several grants to implement cutting edge diagnostic tests at large scale. Pr Loupy is principal investigator and coordinator of international H2020 (EU4health BRAVEST), H2020 (BIOTOOL-CHF), ERC Consolidator Grant (Ai-CARE), MDS Avenir (xenotransplant), inIdEx UPC (SYTOR), H2020 (EU-TRAIN), national RHU (KTD-innov, iTRANSPLANT), projects. He is also PI or co-PI of several on-going clinical trials since 2018.
